This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
PubMed · Existing knowledge on Euphorbia fischeriana Steud. (Euphorbiaceae): Traditional uses, clinical applications, phytochemistry, pharmacology and toxicology. (2021)
PubMed · Cytotoxic Diterpenoids from Euphorbia fischeriana. (2021)
Reviewed by: HerbAlly Editorial Team, Medical herbalists and healthcare professionals
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Euphorbia fischeriana is a perennial herb used in traditional Chinese medicine, primarily recognized for its antitumor, anti-inflammatory, and antitubercular properties [PMID:33819505, 29439483].
Background
Euphorbia fischeriana Steud. (Euphorbiaceae) is a perennial herb distributed in grasslands, hill slopes, or gravel hillsides at altitudes of 100-600m [PMID:33819505].
Traditional uses
The roots are used in folk medicine to treat 'Zhushui', dyspepsia, abdominal distension, abdominal pain, cough, skin ulceration, lymph node tuberculosis, tumors, edema, and scabies [PMID:33819505, 40147679, 29439483, 29669996].
Active compounds
The plant is rich in diterpenoids, including subtypes such as ent-abietane, daphnane, tigliane, ingenane, ent-atisane, ent-rosane, ent-kaurane, and lathyrane [PMID:29439483, 29669996]. Specific active compounds include Jolkinolide B, 12-Deoxyphorbol 13-palmitate (DP), and various phloroglucinol derivatives and triterpenoids [PMID:40616985, 33524514, 29324281, 40378412].
Mechanism of action
Antitumor mechanisms include the induction of apoptosis and cell cycle arrest (G0/G1 phase) via modulation of the PI3K/Akt signaling pathway and upregulation of PTEN [PMID:27073468, 33524514]. Jolkinolide B inhibits M. tuberculosis by down-regulating 17 ribosomal proteins and interfering with protein synthesis [PMID:40616985]. Other mechanisms include the inhibition of Kv1.3 ion channels [PMID:37796721] and impact on NCOA4-mediated ferritinophagy in hepatocellular carcinoma [PMID:40147679].
Clinical evidence
Evidence DHepatocellular Carcinoma (Liver Cancer)
Root extract reduced tumor weight, tumor size, and hepatic index in H22 cell-induced mice models [PMID:37861961].
Evidence DAsthma
Jolkinolide B (10 mg/kg) attenuated allergic airway inflammation, reduced levels of IL-4, IL-5, and IL-13, and improved lung function in OVA-induced mice [PMID:38970271].
Evidence DVarious Cancers (In Vitro)
Diterpenoids showed cytotoxicity against HeLa, H460, Namalwa, MCF-7, HepG2, and prostate cancer (C4-2B) cell lines [PMID:33354895, 36661108, 36364087, 31325614, 35964805, 33359422].
Evidence DTuberculosis
Jolkinolide B exhibited antimycobacterial activity with a minimum inhibitory concentration (MIC) of 3 μg/mL against M. tuberculosis H37Ra [PMID:40616985].
Safety & adverse effects
The whole grass of E. fischeriana is toxic [PMID:33819505]. However, oral acute toxicity studies of certain solvent extracts demonstrated relatively low toxicity [PMID:37446834].
Evidence summary
The majority of evidence is based on in vitro cell line assays and in vivo animal models (Level D), with some systematic reviews (Level C) summarizing traditional uses and phytochemistry. There are no human clinical trials (Level B) or meta-analyses (Level A) provided.
PubMed sources
1.PMID: 33354895 (2021) — Cytotoxic Diterpenoids from Euphorbia fischeriana. · Chemistry & biodiversity
2.PMID: 36661108 (2023) — Antiproliferative ent-abietane diterpenoids from Euphorbia fischeriana. · Natural product research
3.PMID: 40147679 (2025) — Mechanism and molecular targets of Euphorbia fischeriana Steud root extract in hepatocellular carcinoma. · Journal of ethnopharmacology
4.PMID: 33819505 (2021) — Existing knowledge on Euphorbia fischeriana Steud. (Euphorbiaceae): Traditional uses, clinical applications, phytochemistry, pharmacology and toxicology. · Journal of ethnopharmacology
5.PMID: 29439483 (2018) — Anti-Cancer Activities of Diterpenoids Derived from Euphorbia fischeriana Steud.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 29324281 (2018) — Chemical profiling of Euphorbia fischeriana Steud. by UHPLC-Q/TOF-MS. · Journal of pharmaceutical and biomedical analysis
7.PMID: 37796721 (2023) — Diterpenoids from Euphorbia fischeriana with Kv1.3 Inhibitory Activity. · Journal of natural products
8.PMID: 29669996 (2018) — Structural Diversity and Biological Activities of Diterpenoids Derived from Euphorbia fischeriana Steud. · Molecules (Basel, Switzerland)
9.PMID: 33524514 (2021) — DP from Euphorbia fischeriana S. mediated apoptosis in leukemia cells via the PI3k/Akt signaling pathways. · Journal of ethnopharmacology
10.PMID: 40616985 (2025) — Jolkinolide B inhibits mycobacterial growth by down-regulating ribosomal proteins and interfering with protein synthesis. · Bioorganic & medicinal chemistry
11.PMID: 36364087 (2022) — Ent-Abietane Diterpenoids from Euphorbia fischeriana and Their Cytotoxic Activities. · Molecules (Basel, Switzerland)
12.PMID: 31325614 (2019) — Euphonoids A-G, cytotoxic diterpenoids from Euphorbia fischeriana. · Phytochemistry
13.PMID: 39119497 (2024) — Diterpenoids target SARS-CoV-2 RdRp from the roots of Euphorbia fischeriana Steud. · Frontiers in plant science
14.PMID: 27073468 (2016) — Euphorbia fischeriana Steud inhibits malignant melanoma via modulation of the phosphoinositide-3-kinase/Akt signaling pathway. · Experimental and therapeutic medicine
15.PMID: 36087821 (2022) — Structurally diverse diterpenoids from the roots of Euphorbia fischeriana Steud. · Fitoterapia
16.PMID: 31138021 (2021) — Bioactive tigliane diterpenoids from the latex of Euphorbia fischeriana. · Natural product research
17.PMID: 40378412 (2025) — Four new cytotoxic triterpenoids from Euphorbia fischeriana. · Natural product research
18.PMID: 33359422 (2021) — Daphnane-type diterpenoids from Euphorbia fischeriana Steud and their cytotoxic activities. · Fitoterapia
19.PMID: 22389143 (2012) — Anticancer drugs from traditional toxic Chinese medicines. · Phytotherapy research : PTR
20.PMID: 35807527 (2022) — Chemical Composition, Anti-Breast Cancer Activity and Extraction Techniques of Ent-Abietane Diterpenoids from Euphorbia fischeriana Steud. · Molecules (Basel, Switzerland)
21.PMID: 38970271 (2024) — Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice. · Allergologia et immunopathologia
22.PMID: 35349831 (2022) — Cytotoxic diterpenoid dimer containing an intricately caged core from Euphorbia fischeriana. · Bioorganic chemistry
23.PMID: 37446834 (2023) — Phytochemical Analysis, Antioxidant Activities In Vitro and In Vivo, and Theoretical Calculation of Different Extracts of Euphorbia fischeriana. · Molecules (Basel, Switzerland)
24.PMID: 32559489 (2020) — Antiproliferative diterpenoids and acetophenone glycoside from the roots of Euphorbia fischeriana. · Phytochemistry
25.PMID: 35964805 (2022) — Euphorfiatnoids A-I: Diterpenoids from the roots of Euphorbia fischeriana with cytotoxic effects. · Phytochemistry
26.PMID: 39111719 (2024) — Three new diterpenoids from the roots of Euphorbia fischeriana and their cytotoxicity. · Fitoterapia
27.PMID: 37861961 (2024) — Mechanism Exploration of Euphorbia fischeriana Steud. for Liver Cancer Based on Aspartic Acid Identification in Metabolomics. · Chinese journal of integrative medicine